Dova Pharmaceuticals
Latest round
- Series A
Last raised
- Sep 2016
Total raised
- $29M
Investors
- 4
About Dova Pharmaceuticals
Founded in 2005 and based in New Carolina, US, Dova Pharmaceuticals, Inc.) is a biopharmaceutical company that develops AKR-501, a therapeutic medicine for the treatment of thrombocytopenia.
Who invested in Dova Pharmaceuticals
4 investors across 3 rounds
See all investors in Dova Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dova Pharmaceuticals
Who invested in Dova Pharmaceuticals?
Dova Pharmaceuticals has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dova Pharmaceuticals raised?
Dova Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Dova Pharmaceuticals last raise money?
Dova Pharmaceuticals's most recent round on record is a Series A, in Sep 2016.
What does Dova Pharmaceuticals do?
Founded in 2005 and based in New Carolina, US, Dova Pharmaceuticals, Inc.
Where is Dova Pharmaceuticals headquartered?
Dova Pharmaceuticals is headquartered in Durham, US.
Which VCs invest in companies like Dova Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Dova Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Dova Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.